BCR signaling is required for posttransplant lymphoproliferative disease in immunodeficient mice receiving human B cells
Sci Transl Med. 2024 Apr 10;16(742):eadh8846. doi: 10.1126/scitranslmed.adh8846. Epub 2024 Apr 10. ABSTRACT Posttransplant lymphoproliferative disease (PTLD) is a major therapeutic challenge that has been …